2,332 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by Entropy Technologies LP

Entropy Technologies LP acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, Holdings Channel reports. The institutional investor acquired 2,332 shares of the company’s stock, valued at approximately $224,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of HQY. Raymond James Trust N.A. raised its holdings in shares of HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares during the period. UMB Bank n.a. raised its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the period. Truist Financial Corp lifted its position in shares of HealthEquity by 7.0% during the second quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares in the last quarter. Nicolet Advisory Services LLC boosted its stake in shares of HealthEquity by 5.8% in the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after purchasing an additional 233 shares during the period. Finally, Exchange Traded Concepts LLC grew its holdings in HealthEquity by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company’s stock valued at $942,000 after purchasing an additional 245 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of a number of analyst reports. Barrington Research upped their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Bank of America upped their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $110.71.

Insider Buying and Selling at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,000 shares of company stock worth $3,895,788. 2.20% of the stock is owned by insiders.

HealthEquity Price Performance

HQY opened at $113.94 on Friday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company’s 50-day moving average price is $101.90 and its 200 day moving average price is $90.53. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The firm has a market cap of $9.87 billion, a price-to-earnings ratio of 104.53, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm earned $0.40 EPS. As a group, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.